Skip to main content

Get the latest public health information from CDC

Clinicalinfo.HIV.gov logo.
In affiliation with HIV.gov
Main navigation
  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Mobile Application
  • Resources
  • Contact Us
  • English
  • Español (Spanish)
  1. Home
  2. News

News

Read important news and announcements from Clinicalinfo. Stay up-to-date on HIV and AIDS-related news.

News

Search Results 1 – 15 of 303

Awareness day logo.

National Women and Girls HIV/AIDS Awareness Day
Date: Mar. 10, 2023
Source: HIVinfo.NIH.gov

The National Women and Girls HIV/AIDS Awareness Day started on March 10, 2005. This day highlights the impact HIV and AIDS has on women and girls, and ongoing efforts to reduce HIV and AIDS among women and girls in the United States.  

 

 

diverse group of females

NIH Symposium Launches OAR-ORWH Partnership to Advance Research on HIV and Women Across the Lifespann
Date: Mar. 10, 2023
Source: NIH Office of AIDS Research (OAR)

The NIH Office of AIDS Research (OAR) and Office of Research on Women’s Health (ORWH) co-sponsored the NIH OAR-ORWH Women & HIV Symposium: Considerations from Across the Lifespan during the 13th International Workshop on HIV & Women 2023 in Seattle, Washington.

 

 

Expecting parents holding their hands and showing the ultrasound image of their future baby.

Updates to the Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States
Date: Jan. 31, 2023
Source: Clinicalinfo.HIV.gov

The Panel on Treatment of HIV in Pregnancy and Prevention of Perinatal Transmission (the Panel) updated the Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States.

Clinicians meeting.

The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents with HIV is Accepting Applications for Scientific/Clinical Members
Date: Jan. 23, 2023
Source: Clinicalinfo.HIV.gov

The Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents (or the Panel) is accepting applications for new scientific/clinical members with expertise in HIV medicine.

A decorative image.

Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
Date: Jan. 18, 2023
Source: Clinicalinfo.HIV.gov

The Panel on Opportunistic Infections in Adults and Adolescents (the Panel) updated the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV.

The screenshot of the Clinicalinfo website on the mobile device.

Clinicalinfo Website Now Optimized for Mobile Browsing: App to Sunset on December 30
Date: Dec. 20, 2022
Source: Clinicalinfo.HIV.gov

The Clinicalinfo mobile application, which was originally created to provide mobile access to the resources now available on the optimized website, will sunset on December 30, 2022.

A decorative image.

December 1: NIH World AIDS Day Event
Date: Nov. 28, 2022
Source: NIH OAR

The event will be broadcast live via NIH Videocast on Thursday, December 1, 2022, from 1:00 to 2:30 p.m. ET.
Join a distinguished group of participants for a live discussion as NIH marks the global World AIDS Day observance.

World AIDS Day logo.

Save the Date: NIH World AIDS Day 2022 Virtual Event
Date: Nov. 16, 2022
Source: NIH OAR

Please save the date for the NIH World AIDS Day 2022 Virtual Event: Progress and Promise in HIV Research.

 

 

Two scientists in the lab.

Scientific/Clinical Member Nominations are Now Being Accepted for the Department of Health and Human Services Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV
Date: Nov. 04, 2022
Source: Clinicalinfo

The HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV (or the Panel) is accepting nominations for new scientific/clinical members with expertise in HIV medicine. 

A multi-generational group of Latin-Americans.

National Latinx AIDS Awareness Day Resources
Date: Oct. 14, 2022
Source: HIVinfo.NIH.gov

National Latinx AIDS Awareness Day (NLAAD) is a day to raise awareness about the impact of HIV on the Hispanic/Latino communities in the United States.

Drugs.

Updates to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
Date: Oct. 11, 2022
Source: Clinicalinfo

The Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV (the Panel) has made revisions to address U.S. Food and Drug Administration approval of the dispersible tablet formulation of the fixed-dose combination abacavir/dolutegravir/lamivudine (Triumeq PD) for use in children weighing 10 kg to 25 kg and the long-acting injectable cabotegravir and rilpivirine (Cabenuva) for use in children and adolescents aged ≥12 years and weighing ≥35 kg.

A decorative image.

Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
Date: Sep. 28, 2022
Source: Clinicalinfo

The Panel on Opportunistic Infections in Adults and Adolescents (the Panel) updated the monkeypox section of the guidelines.

Lesbian, Gay, Bisexual, and Transgender (LGBTQ+) flag.

National Gay Men’s HIV/AIDS Awareness Day Resources
Date: Sep. 27, 2022
Source: HIVinfo.NIH.gov

September 27 is National Gay Men’s HIV/AIDS Awareness Day. The annual observance is held each year to focus attention on the disproportionate impact of HIV and AIDS on gay and bisexual men.

2022 AIDS Conference - watch a video.

Reflections on the AIDS 2022 Global Village
Date: Sep. 22, 2022
Source: NIH OAR

The National Institutes of Health (NIH) Office of AIDS Research (OAR) joined the world's largest gathering on HIV/AIDS at the 24th International AIDS Conference (AIDS 2022).

 

A decorative image.

Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV
Date: Sep. 21, 2022
Source: Clinicalinfo

The Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) updated several sections of the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV.

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page ›
  • Last page »

CONNECT WITH US

Facebook
Twitter
Instagram
Email Updates

Footer menu

  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Mobile Application
  • Resources
  • Contact Us
  • Privacy Policy
  • Sponsors
  • Nondiscrimination Notice
  • Disclaimers
  • Accessibility
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.